Kidney Function Tests Market Analysis Report By Product, By End Use, By Region And Segment Forecasts From 2021 To 2028

Synopsis

With reference to the report published, the global kidney function tests market size was prized by USD 777.06 million in 2020. It is estimated to witness a 6.2% CAGR from 2021 to 2028.

Drivers

The kidney function tests are easy laboratory tests, intended to examine and assess the work of the kidney. The factors, like greater frequency of kidney sickness, increasing proposals by the government, rising R&D actions, as well as the funds by the companies, are some of the factors, estimated to considerably push the expansion of the market.

The augmented threat of Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD) caused by the increasing frequency of hypertension, along with diabetes, has radically increased the requirement for these products. The eruption of coronavirus has, furthermore, powered the demand for kidney function tests.

Consistent with the report, published by the National Kidney Foundation, citizens hospitalized owing to the Covid-19 are having the larger possibility of increasing Acute Kidney Injury (AKI). The report confirmed that Covid-19 patients were two times more prone to form Acute Kidney Injury (AKI), in contrast to non-Covid-19 patients.

Healthcare experts suggested that the Covid-19 patients, who possess an Acute Kidney Injury (AKI), must be tested frequently, since their threat of increasing Chronic Kidney Disease (CKD) is greater than the others. These issues will push the enlargement of the market for kidney function tests, during the forecast period.

Increasing R&D programs for the advancement of new products are anticipated to drastically increase the expansion of the kidney function tests market, for the duration of the forecast. Additionally, numerous public-private associations are taking on the projects to make possible the testing of kidney ailment, in main regions. Such as, the National Kidney Foundation (NKF) in association with the National Committee for Quality Assurance (NCQA) launched an innovative kidney health assessment gauge, particularly for those patients having diabetes, in July 2020.

The latest guiding principles recommend regular checks of diabetes patients for kidney sickness. Such proposals are expected to generate, a profitable background for the escalation of the market.

Effect of Covid-19

The majority apprehension for all the governments of the Covid-19 influenced nation is the severe requirement to monitor and an examination of outsized records of the patients for the probable Sars-Cov-2 disease. Accordingly, the majority of them are in front of major scarcity in the source for diagnostic kits, to check for the virus. Diagnostics virology units are below huge pressure, to offer dependable testing kits, and there is a gush in demand for the point-of-care testing capability, via labs, from a number of nation-states.

Product Insight

The clearance tests sector held the most important 28.73% share of the kidney function test market, in 2020. It is estimated to maintain its domination for the forecast period. For the measurement and checking of glomerular filtration value, clearance tests are considered as the gold rank. These products comprise insulin as well as creatinine test that offers an essential addition to usual investigative tests to get the exact outcome. Furthermore, these tests guarantee that there is the least discrepancy in presentation, due to their best accuracy and sensitivity. The less price and simple availability of these products in the market cause their augmented acceptance.

The urine tests sector is estimated to record the highest CAGR, during the forecast period. This can be credited to the extensive range of the function of these products, together with kidney stones, diabetes, detection of Urinary Tract Infections (UTIs), pregnancy, high blood pressure, and the rest. Besides, the discovery of prescription drug mistreatment that can be completed with the assistance of urine tests and growth in PoC diagnostics together with the small prices of these tests, are estimated to increase the enlargement of the section.

End-Use Insight

The hospital's sector retained the major 53.89% share of the kidney function tests market, in 2020 and is expected to maintain the foremost place, all through the forecast period. This high-level share is credited to the growing hospital appointments, because of the increasing knowledge on the subject of Chronic Kidney Disease (CKD) as well as its therapy. The advancement of the highly developed infrastructures, through a variety of regions that assist in effectively carrying out the diagnostic actions, will moreover add to the share of the section.

The lead taken by the healthcare institutes, globally, to encourage the usage of highly developed diagnostic tests, along with the beneficial compensation situation are the factors, furthermore, expected to power the sector.

Since these labs are capable to perform a big amount of tests, give precise results and are profitable, the diagnostic laboratories section is, moreover, expected to form a considerable share of the market, by 2028. Due to the rising R&D actions, within Europe and North America, the research laboratories and institutes section is estimated to record the highest CAGR, during the forecast period.

Regional Insight

North America retained the biggest 39.10% market share, in 2020. Owing to greater alertness levels regarding Chronic Kidney Disease (CKD), encouraging programs by the government, positive repayment strategy, and entrenched healthcare infrastructure, North America is anticipated to keep up its domination; all through the study phase. The U.S. is responsible for the principal share in the North American local market. The important features, favorable for its supremacy, comprise the attendance of key market players as well as the easy availability of the technically highly developed products, in the local market.

Because of the speedily increasing healthcare amenities along with an enlargement in the funds by the top market players, Asia Pacific is estimated to be the rapidly developing local market for kidney function tests, during the forecast period. In addition, the existence of a huge targeted populace in the rising nations, like India and China; it is anticipated to impel the local market in the duration of the forecast. Such as, consistent with the information published by the NCBI, the general occurrence of Chronic Kidney Disease (CKD) in India is approximately 17.20%.

Companies

The major companies, working in the market, are taking on various development policies, such as partnerships as well as collaborations, to increase their geological spread.

For example, in September 2020, Baxter International, Inc. signed a tactical coalition with bioMérieux, meant for the sharing of NEPHROCLEARTM CCL14 tests. The test is under improvement process, at present. The NEPHROCLEARTM CCL14 test is intended to measure the possibility of continual acute AKI.

Some of the companies for kidney function tests market are:

    • Nova Biomedical
    • Quest Diagnostics
    • Siemens Healthineers
    • F. Hoffmann-La Roche
    • Abbott Laboratories
    • Laboratory Corporation of America Holdings (LabCorp)
    • Acon Laboratories
    • Randox Laboratories
    • Sysmex Corporation
    • Danaher Corporation (Beckman Coulter, Inc.)

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Million Insights has segmented the global kidney function tests market report on the basis of product, end-use, and region:

• Product Outlook (Revenue, USD Million, 2016 - 2028)
    • Clearance Tests
    • Urine Tests
    • Blood Tests
    • Dilution and Concentration Tests
    • Other Tests

• End-use Outlook (Revenue, USD Million, 2016 - 2028)
    • Hospitals
    • Diagnostic Laboratories
    • Research Laboratories and Institutes
    • Others

• Regional Outlook (Revenue, USD Million, 2016 - 2028)
    • North America
        • U.S.
        • Canada
    • Europe
        • U.K.
        • Germany
        • Spain
        • France
        • Italy
        • Russia
    • Latin America
        • Brazil
        • Mexico
        • Argentina
    • The Asia Pacific
        • Japan
        • China
        • India
        • South Korea
        • Singapore
        • Australia
    • MEA
        • South Africa
        • Saudi Arabia
        • UAE